ReviewProbiotics and antimicrobial proteins2026
Targeting Eustachian Tube Microenvironment: Probiotic Surfactant Utilization for Antimicrobial Peptide Secretion to Prevent Otitis Media.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Otitis media prevention remains challenging due to antibiotic resistance and frequent recurrence. This review proposes a novel strategy based on probiotic modulation of the Eustachian tube microenvironment. The approach leverages a dual-mechanism whereby probiotics secrete biosurfactants that contribute to the restoration of physiological surface tension and mucus flow, while simultaneously producing antimicrobial peptides that directly eliminate pathogens and suppress inflammatory responses. This synergistic action may not only facilitates sustainable colonization by beneficial bacteria but also disrupts the cycle of biofilm formation and functional impairment in the Eustachian tube. Experimental evidence and clinical observations indicate that this probiotic-based intervention correlates with significantly reduced incidence of otitis media and decreased recurrence rates. Future translation into clinical practice will require further development of optimized strain-specific formulations and effective delivery systems to fully realize this therapeutic approach. This review aims to critically evaluate current evidence supporting probiotic-mediated modulation of the Eustachian tube microenvironment, with particular emphasis on the complementary roles of biosurfactants and antimicrobial peptides in preventing otitis media, while highlighting the current limitations and future translational challenges. These findings highlight the potential of probiotic-mediated modulation of the Eustachian tube environment as a promising preventive strategy.
Indexed as
Identifiers
42606638What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.